Associating growth-phase-related changes in the proteome of Acinetobacter baumannii with increased resistance to oxidative stress

Journal of Proteome Research
Nelson C SoaresGerman Bou

Abstract

Acinetobacter baumannii is an opportunistic pathogen that has been associated with severe infections and outbreaks in hospitals. At present, very little is known about the biology of this bacterium, particularly as regards mechanisms of adaptation, persistence and virulence. To investigate the growth phase-dependent regulation of proteins in this microorganism, we analyzed the proteomic pattern of A. baumannii ATCC 17978 at different stages of in vitro growth. In this study, proteomics analyses were conducted using 2-DE and MALDI-TOF/TOF complemented by iTRAQ LC-MS/MS. Here we have identified 107 differentially expressed proteins. We highlight the induction of proteins associated with signaling, putative virulence factors and response to stress (including oxidative stress). We also present evidence that ROS (O(2)(-) and OH(-)) and RNI (ONOO(-)) accumulate during late stages of growth. Further assays demonstrated that stationary cells survive at high concentrations of H(2)O(2) (30 mM), the O(2)(-) donor menadione (500 muM) or the NO donor sodium nitroprusside (1 mM), and showed a higher survival rate against several bactericidal antibiotics. The growth phase-dependent changes observed in the A. baumannii proteome are discussed w...Continue Reading

References

Nov 1, 1992·Chemical Research in Toxicology·W H KoppenolJ S Beckman
Jan 1, 1991·Journal of Bacteriology·I von OssowskiP C Loewen
Mar 1, 1990·Journal of Bacteriology·A RobinR D'Ari
Jul 30, 1990·FEBS Letters·Z Y JiangS P Wolff
Dec 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D J Hassett, M S Cohen
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T NunoshibaB Demple
Jan 1, 1996·Free Radical Biology & Medicine·A EisenstarkA Ivanova
Jun 15, 1999·Journal of Bacteriology·B González-Flecha, B Demple
Aug 14, 1999·Molecular Microbiology·B K Hammer, M S Swanson
May 12, 2000·European Journal of Biochemistry·M P MolloyA A Gooley
Feb 6, 2002·Journal of Molecular Biology·Gauri M DhavanMichael Brenowitz
Feb 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Karen Otto, Thomas J Silhavy
Mar 12, 2002·Traffic·Michele S SwansonEsteban Fernandez-Moreia
Apr 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hugues OuelletMichel Guertin
Sep 6, 2003·Journal of Clinical Microbiology·Caleb W DorseyLuis A Actis
Jul 31, 2004·Annals of Clinical Microbiology and Antimicrobials·Mark E JonesRichard P Wenzel
Oct 19, 2004·Annual Review of Microbiology·Thomas Nyström
Jan 13, 2006·The Journal of Urology·Lovisa SvenssonKatarina Persson
Oct 20, 2006·Journal of Bacteriology·Nicolas BarraudJeremy S Webb
Sep 7, 2007·Cell·Gerard D Wright
Sep 7, 2007·Cell·Michael A KohanskiJames J Collins
Nov 17, 2007·Nature Reviews. Microbiology·Lenie DijkshoornHarald Seifert
Jan 5, 2008·Annual Review of Biochemistry·James A Imlay
Jan 15, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J Rodríguez-BañoUNKNOWN Spanish Group for the Study of Nosocomial Infections (GEIH)

❮ Previous
Next ❯

Citations

Dec 20, 2011·PloS One·Scott A WeisenbergKyu Y Rhee
Mar 8, 2013·Future Microbiology·Steven E Fiester, Luis A Actis
Mar 15, 2016·Frontiers in Microbiology·Annika C MosierJillian F Banfield
Feb 20, 2015·Applied Microbiology and Biotechnology·Jaejoon Jung, Woojun Park
Oct 14, 2014·Frontiers in Microbiology·Vishvanath Tiwari, Monalisa Tiwari
Jan 4, 2012·FEMS Immunology and Medical Microbiology·Anna C JacobsPaul M Dunman
Feb 1, 2011·FEMS Microbiology Letters·Cecilia Di CapuaNéstor Cortez
Sep 25, 2014·Annual Review of Pharmacology and Toxicology·Daniel J DwyerGraham C Walker
Apr 18, 2013·Journal of Proteome Research·Nelson C SoaresBoris Macek
Sep 13, 2012·Journal of Proteome Research·Jose Antonio MendezGermán Bou
Jul 27, 2011·Journal of Proteome Research·Shailesh JainNigel G Ternan
Nov 2, 2016·Molecular & Cellular Proteomics : MCP·Takfarinas KentacheJulie Hardouin
Oct 3, 2018·MicrobiologyOpen·Sabine Zeidler, Volker Müller
Nov 23, 2017·Frontiers in Microbiology·Han-Yueh KuoMing-Li Liou
Oct 19, 2021·Frontiers in Microbiology·Sébastien MassierJulie Hardouin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.